Dr. Alicia R. Camlibel, PH.D., LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3644 Valley Road, Liberty Corner, NJ 07938 Phone: 908-647-1228 |
Ms. Mary-elizabeth Eleanor Fuentes, LPC. LCADC, NCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 20 Church Street, Liberty Corner, NJ 07938 Phone: 973-348-5919 |
Lisa Ann Volante, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3640 Valley Road, Liberty Corner, NJ 07938 Phone: 908-484-7354 |
Kaitlin Najjar, MA, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3640 Valley Rd, Liberty Corner, NJ 07938 Phone: 908-484-7354 |
News Archive
The journal Accounts of Chemical Research, which has a profound impact on Chemistry and other related sciences, publishes on its current issue the article "Anion Transporters and Biological Systems", signed by Professor Ricardo Pérez Tomás, from the Department of Pathology and Experimental Therapy of the Faculty of Medicine at the University of Barcelona, Roberto Quesada, from the Department of Chemistry of the Sciences Faculty at the University of Burgos, and Philip A. Gale, from the University of Southampton, in the United Kingdom.
Janssen Pharmaceuticals, Inc.announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A.
Four Geisinger Health System researchers have taken center stage in the national arena of genomics thanks to new funding from the National Human Genome Research Institute (NHGRI), an arm of the U.S. National Institutes of Health (NIH).
The Republican governor pushed the state legislature to expand Medicaid coverage to most poor people in the state.
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it has reached an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V. (JANSSEN), to collaborate in the area of preclinical services.
› Verified 1 days ago